- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03934489
Recruitment Status Recruiting
First Posted May 2, 2019
Last update posted August 18, 2020
This pilot randomized controlled trial investigates a novel, group-based emotion regulation skills training intervention for reducing anxious and depressive symptomatology and improving emotion regulation and problem solving in individuals with MS and the individual's support partners. Participants will be randomized (1:1) to the intervention ("Partnered Emotion Regulation Skills Intervention and Supportive Teaching [PERSIST]") or to the active control (Facilitated Peer Support).
Participants will receive Partnered Emotion Regulation Skills Intervention and Support.
12-week group, adapted from Dialectical Behavior Therapy, that focuses on emotion regulation skills training and practice.
|Active Comparator: Facilitated Peer Support
Participants will undergo a 12-week group intervention, adapted from community-based peer support groups, that focuses on participant-generated topics and facilitated discussion.
Behavioral: Facilitated Peer Support
12-week group, adapted from community-based peer support groups, that focuses on participant-generated topics and facilitated discussion.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
- at least 18 years old
- able to speak/read in English
- able to commit to attending at least 9 of the 12 weekly group sessions
- individuals with MS must be relapse/exacerbation-free for at least 1 month
- support partners must score at least 8 on the HADS-D or HADS-A
- individuals with MS must score a least 11 on the HADS-D or HADS-A
- under 18 years old
- unable to speak/read in English
- unable to commit to attending at least 9 of the 12 weekly group sessions
- MS relapse within 1 month
Contact: Abbey Hughes, PhD 410-502-9234 email@example.com
Contact: Meghan Beier, PhD 410-502-2441 firstname.lastname@example.org
United States, Maryland
Johns Hopkins University
Johns Hopkins University
National Multiple Sclerosis Society
Principal Investigator: Abbey Hughes, PhD Johns Hopkins University